Company
United StatesPublic company, NASDAQ: LINLinde, Inc. (NASDAQ: LIN), River Rouge, MI – FDA Inspections
Inspection records and compliance data for Linde, Inc. in River Rouge, Michigan. 2 FDA inspections on record, last inspected July 14, 2015. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde, Inc. based in River Rouge, Michigan, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected September 25, 2013. Last inspected July 14, 2015.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 14, 2015 | NAI | Human Drugs · Drug Quality Assurance | 934268 |
| September 25, 2013 | VAI | Human Drugs · Drug Quality Assurance | 849748 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde, Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1818983
Address
300 E Great Lakes St, River Rouge, Michigan 48218, United States
Country
United States
ID: 40917901-3075-4fc3-8020-ec66454795d2